Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma

被引:33
作者
Valcamonico, Francesca [1 ]
Ferrari, Vittorio [1 ]
Amoroso, Vito [1 ]
Rangoni, Giovanni [1 ]
Simoncini, Edda [1 ]
Marpicati, Patrizia [1 ]
Vassalli, Lucia [1 ]
Grisanti, Salvatore [1 ]
Marini, Giovanni [1 ]
机构
[1] Spedali Civili Brescia, Dept Med Oncol, Brescia, Italy
关键词
Advanced renal cell carcinoma; Sorafenib; Brain metastases; ANTITUMOR-ACTIVITY; TRIAL;
D O I
10.1007/s11060-008-9676-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the case of a 75-year old woman who received sorafenib (Nexavar (R), Bayer Pharmaceuticals Corporation, West Haven, CT) for a CNS relapse of clear cell renal cell carcinoma. After four months of sorafenib treatment, a brain magnetic resonance imaging showed 95%-volumetric regression of cerebral metastasis. To the best of our knowledge, this is the first almost complete resolution of brain metastases in renal cell carcinoma treated with sorafenib that has been described.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 15 条
[1]   Protein kinase inhibitors in the treatment of renal cell carcinoma:: sorafenib [J].
Bracarda, S. ;
Caserta, C. ;
Sordini, L. ;
Rossi, M. ;
Hamzay, A. ;
Crino, L. .
ANNALS OF ONCOLOGY, 2007, 18 :22-25
[2]  
CHANG YS, 2005, P AM ASS CANC RES, V46
[3]   Renal-cell carcinoma [J].
Cohen, HT ;
McGovern, FJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2477-2490
[4]   Renal cell carcinoma: New developments in molecular biology and potential for targeted therapies [J].
Costa, Luciano J. ;
Drabkin, Harry A. .
ONCOLOGIST, 2007, 12 (12) :1404-1415
[5]   Sorafenib in advanced clear-cell renal-cell carcinoma [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Siebels, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Solska, Ewa ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Freeman, Scott ;
Schwartz, Brian ;
Shan, Minghua ;
Simantov, Ronit ;
Bukowski, Ronald M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :125-134
[6]   Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis [J].
Flanigan, RC ;
Mickisch, G ;
Sylvester, R ;
Tangen, C ;
Van Poppel, H ;
Crawford, ED .
JOURNAL OF UROLOGY, 2004, 171 (03) :1071-1076
[7]   Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: Establishing a treatment paradigm [J].
Gerstner, Elizabeth R. ;
Fine, Robert L. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) :2306-2312
[8]  
Massard C, 2006, ANN ONCOL, V17, P148
[9]   Complete cerebral response with sunitinib for metastatic renal cell carcinoma [J].
Medioni, J. ;
Cojocarasu, O. ;
Belcaceres, J.-L. ;
Halimi, P. ;
Oudard, S. .
ANNALS OF ONCOLOGY, 2007, 18 (07) :1282-1283
[10]   Renal-cell carcinoma [J].
Motzer, RJ ;
Bander, NH ;
Nanus, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :865-875